264 related articles for article (PubMed ID: 26972529)
1. The role of CHMP2B
Krasniak CS; Ahmad ST
Brain Res; 2016 Oct; 1649(Pt B):151-157. PubMed ID: 26972529
[TBL] [Abstract][Full Text] [Related]
2. TMEM106B, a frontotemporal lobar dementia (FTLD) modifier, associates with FTD-3-linked CHMP2B, a complex of ESCRT-III.
Jun MH; Han JH; Lee YK; Jang DJ; Kaang BK; Lee JA
Mol Brain; 2015 Dec; 8():85. PubMed ID: 26651479
[TBL] [Abstract][Full Text] [Related]
3. Expression of mutant CHMP2B, an ESCRT-III component involved in frontotemporal dementia, causes eye deformities due to Notch misregulation in Drosophila.
Cheruiyot A; Lee JA; Gao FB; Ahmad ST
FASEB J; 2014 Feb; 28(2):667-75. PubMed ID: 24158394
[TBL] [Abstract][Full Text] [Related]
4. A transgenic mouse expressing CHMP2Bintron5 mutant in neurons develops histological and behavioural features of amyotrophic lateral sclerosis and frontotemporal dementia.
Vernay A; Therreau L; Blot B; Risson V; Dirrig-Grosch S; Waegaert R; Lequeu T; Sellal F; Schaeffer L; Sadoul R; Loeffler JP; René F
Hum Mol Genet; 2016 Aug; 25(15):3341-3360. PubMed ID: 27329763
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotective activity of ursodeoxycholic acid in CHMP2B
West RJH; Ugbode C; Fort-Aznar L; Sweeney ST
Neurobiol Dis; 2020 Oct; 144():105047. PubMed ID: 32801000
[TBL] [Abstract][Full Text] [Related]
6. Molecular Genetics of Frontotemporal Dementia Elucidated by
Vandal SE; Zheng X; Ahmad ST
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29890743
[TBL] [Abstract][Full Text] [Related]
7. CHMP2B mutants linked to frontotemporal dementia impair maturation of dendritic spines.
Belly A; Bodon G; Blot B; Bouron A; Sadoul R; Goldberg Y
J Cell Sci; 2010 Sep; 123(Pt 17):2943-54. PubMed ID: 20699355
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal transcriptomic analysis of altered pathways in a CHMP2B
Waegaert R; Dirrig-Grosch S; Parisot F; Keime C; Henriques A; Loeffler JP; René F
Neurobiol Dis; 2020 Mar; 136():104710. PubMed ID: 31837425
[TBL] [Abstract][Full Text] [Related]
9. Alteration of the Neuromuscular Junction and Modifications of Muscle Metabolism in Response to Neuron-Restricted Expression of the CHMP2B
Waegaert R; Dirrig-Grosch S; Liu H; Boutry M; Luan P; Loeffler JP; René F
Biomolecules; 2022 Mar; 12(4):. PubMed ID: 35454086
[TBL] [Abstract][Full Text] [Related]
10. Expression of a human variant of CHMP2B linked to neurodegeneration in Drosophila external sensory organs leads to cell fate transformations associated with increased Notch activity.
Wilson C; Kavaler J; Ahmad ST
Dev Neurobiol; 2020 Mar; 80(3-4):85-97. PubMed ID: 31587468
[TBL] [Abstract][Full Text] [Related]
11. ESCRT-III dysfunction causes autophagosome accumulation and neurodegeneration.
Lee JA; Beigneux A; Ahmad ST; Young SG; Gao FB
Curr Biol; 2007 Sep; 17(18):1561-7. PubMed ID: 17683935
[TBL] [Abstract][Full Text] [Related]
12. Frontotemporal dementia caused by CHMP2B mutation is characterised by neuronal lysosomal storage pathology.
Clayton EL; Mizielinska S; Edgar JR; Nielsen TT; Marshall S; Norona FE; Robbins M; Damirji H; Holm IE; Johannsen P; Nielsen JE; Asante EA; Collinge J; ; Isaacs AM
Acta Neuropathol; 2015 Oct; 130(4):511-23. PubMed ID: 26358247
[TBL] [Abstract][Full Text] [Related]
13. The enhanced association between mutant CHMP2B and spastin is a novel pathological link between frontotemporal dementia and hereditary spastic paraplegias.
Chen Y; Krishnan G; Parsi S; Pons M; Nikolaki V; Cao L; Xu Z; Gao FB
Acta Neuropathol Commun; 2022 Nov; 10(1):169. PubMed ID: 36414997
[TBL] [Abstract][Full Text] [Related]
14. Expression of mutant CHMP2B linked to neurodegeneration in humans disrupts circadian rhythms in
Lee D; Zheng X; Shigemori K; Krasniak C; Bin Liu J; Tang C; Kavaler J; Ahmad ST
FASEB Bioadv; 2019 Aug; 1(8):511-520. PubMed ID: 32123847
[TBL] [Abstract][Full Text] [Related]
15. A novel synaptopathy-defective synaptic vesicle protein trafficking in the mutant CHMP2B mouse model of frontotemporal dementia.
Clayton EL; Bonnycastle K; Isaacs AM; Cousin MA; Schorge S
J Neurochem; 2022 Feb; 160(3):412-425. PubMed ID: 34855215
[TBL] [Abstract][Full Text] [Related]
16. Disruption of endocytic trafficking in frontotemporal dementia with CHMP2B mutations.
Urwin H; Authier A; Nielsen JE; Metcalf D; Powell C; Froud K; Malcolm DS; Holm I; Johannsen P; Brown J; Fisher EM; van der Zee J; Bruyland M; ; Van Broeckhoven C; Collinge J; Brandner S; Futter C; Isaacs AM
Hum Mol Genet; 2010 Jun; 19(11):2228-38. PubMed ID: 20223751
[TBL] [Abstract][Full Text] [Related]
17. Frontotemporal dementia caused by CHMP2B mutations.
Isaacs AM; Johannsen P; Holm I; Nielsen JE;
Curr Alzheimer Res; 2011 May; 8(3):246-51. PubMed ID: 21222599
[TBL] [Abstract][Full Text] [Related]
18. Lessons learned from CHMP2B, implications for frontotemporal dementia and amyotrophic lateral sclerosis.
Ugbode C; West RJH
Neurobiol Dis; 2021 Jan; 147():105144. PubMed ID: 33144171
[TBL] [Abstract][Full Text] [Related]
19. Patient iPSC-Derived Neurons for Disease Modeling of Frontotemporal Dementia with Mutation in CHMP2B.
Zhang Y; Schmid B; Nikolaisen NK; Rasmussen MA; Aldana BI; Agger M; Calloe K; Stummann TC; Larsen HM; Nielsen TT; Huang J; Xu F; Liu X; Bolund L; Meyer M; Bak LK; Waagepetersen HS; Luo Y; Nielsen JE; ; Holst B; Clausen C; Hyttel P; Freude KK
Stem Cell Reports; 2017 Mar; 8(3):648-658. PubMed ID: 28216144
[TBL] [Abstract][Full Text] [Related]
20. The functional analysis of the CHMP2B missense mutation associated with neurodegenerative diseases in the endo-lysosomal pathway.
Han JH; Ryu HH; Jun MH; Jang DJ; Lee JA
Biochem Biophys Res Commun; 2012 May; 421(3):544-9. PubMed ID: 22521643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
